Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arechar Healthcare is an Indian pharmaceutical company specializing in the manufacture, export, and distribution of high-quality generic medicines and finished dosage formulations. The company's product portfolio primarily focuses on critical therapeutic areas such as oncology, HIV, and hepatitis. Key branded generic products offered by Arechar include Pegdoxine (pegylated liposomal doxorubicin), Fulvant (fulvestrant), Sunicine (sunitinib), and Abiracine (abiraterone acetate). Operating out of New Delhi, India, Arechar Healthcare serves patients globally by providing affordable, WHO-GMP certified life-saving drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arechar Healthcare.